Topolog
View all posts »Lipoprotein(a): a causal factor for coronary disease
Jan 7, 2010 10:30 EST-
3Comments
-
Read later
A striking and impressive study of the genomics of CAD raises practical questions: should we be measuring LPA genetic variants to assess the risk of coronary disease? Should Lp(a) levels be modulated with drugs such as niacin or other alternatives?
See:
Strongest evidence yet that Lp(a) causes heart disease
Lp(a) is a causal factor for CVD, but a modest one
New data show that Lp(a) is a causal factor for MI, researchers say
Clarke R, Peden JF, Hopewell JC et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009; 361: 2518-2528. Available at: www.nejm.org.
|
||||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!













